Never Overlook Documentation Steps During GMP Change Control

Do Not Skip Documentation Steps in Change Control Processes

Remember: All GMP change control steps—from initiation to closure—must be fully documented to ensure traceability, accountability, and regulatory compliance.

Why This Matters in GMP

Change control is a formal GMP system used to evaluate, approve, and implement modifications to processes, systems, materials, or documents. Skipping documentation steps—such as risk assessment, QA impact analysis, or final approval—undermines the system’s integrity. Incomplete records make it impossible to trace the rationale behind changes, verify effectiveness, or conduct retrospective reviews. This can lead to deviations, audit findings, or non-compliant practices being unintentionally introduced. Change control must be thorough, consistent, and governed by SOPs. Each stage—from initiation to implementation—requires documentation to maintain GMP control.

Also Read: Qualify HVAC Systems in Warehouses to Maintain GMP Storage Conditions

Regulatory and Compliance Implications

FDA 21 CFR Part 211.100 and 211.160 require changes to be documented and supported by data, including SOP revisions and impact evaluations. EU GMP Chapter 1 details the requirements for Quality Management Systems, emphasizing change control with full documentation, risk assessment, and closure procedures. Schedule M mandates that all changes affecting quality be recorded and approved. WHO GMP guidelines insist on using a documented change management procedure to evaluate proposed modifications for risk and

impact.

Regulators review change control logs, approval hierarchies, risk analysis forms, and closure reports. Missing signatures, absent justifications, or incomplete assessments lead to data integrity concerns and potential audit failures. Uncontrolled or undocumented changes may also be interpreted as an attempt to bypass validation or QA review. Change control is a key area of focus during both routine audits and data integrity inspections.

Also Read: Using Third-Party Microbiology and EM Vendors Without Losing Control

Implementation Best Practices

Establish a structured change control SOP with defined stages and responsibilities.
Document impact assessment across validation, documentation, equipment, and regulatory submissions.
Assign QA to approve, verify, and close all change records with final effectiveness checks.
Use digital tools with audit trails to capture version history and approval timestamps.
Train all departments on when and how to initiate change control requests.

Regulatory References

FDA 21 CFR Part 211.100 – Written Procedures; Deviations
FDA 21 CFR Part 211.160 – Laboratory Controls and Change Documentation
EU GMP Chapter 1 – Pharmaceutical Quality System
WHO GMP – Change Control Systems
Schedule M – Documentation and Change Control

Also Read: Never Use Photocopies as Originals for GMP Quality Documents